Targeted nanoparticles reduce tumor scarring and enable immunotherapy response in mice

Дата публикации: 25-09-2026 16:00:20

Many liver and lung cancers arise in tissue that's already been scarred by chronic disease, such as hepatitis, cirrhosis or long-term lung damage. That scarring creates an environment that suppresses nearby immune cells, so by the time a tumor takes hold, it's often already shielded from the immune system and immunotherapy.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Engineered nanoparticles sensitize gliomas to radiotherapy	0	9.54	21-09-2026
2	Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma	0	15.89	10-09-2026
3	Q&A: Combining diagnosis, staging, tumor localization and surgery into a minimally invasive procedure for lung cancer	0	6.9	02-09-2026
4	Ученые научили иммунитет атаковать опухоли, которых не касалось лечение	0	9.4	03-10-2026
5	New nanoparticle drug-delivery method may improve treatment for endometriosis	0	9.82	21-09-2026
6	Tumor response to immunochemotherapy may spare some head and neck cancer patients radical surgery	0	7.22	10-09-2026
7	Surgical Outcomes of Perioperative Toripalimab in Stage III Resectable Non–Small Cell Lung Cancer	0	6.4	01-09-2026
8	Study identifies potential RAS inhibitor-immunotherapy strategy for pancreatic cancer	0	7.48	23-09-2026
9	From professor to patient: One man's journey on the frontier of lung cancer treatment	0	7.28	27-09-2026
10	From professor to patient: One man's journey on the frontier of lung cancer treatment	0	7.28	27-09-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.8. Источник: phys.org.